Seres Therapeutics, Inc. ($MCRB)
Filing Information
| Accession Number | 0001193125-26-230728 |
|---|---|
| Form Type | 4 |
| Filing Date | May 19, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
567
Total Value
$594.87
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP and Chief Legal Officer | Common Stock | โ | May 15, 2026 | Exercise/Conversion | 244 | โ | โ | 8,033 | Direct | โ | View Details | |
EVP and Chief Legal Officer | Common Stock | โ | May 18, 2026 | Sale | 79 | $7.53 | $594.87 | 7,954 | Direct | โ | View Details | |
EVP and Chief Legal Officer | Restricted Stock Units | Derivative | May 15, 2026 | Exercise/Conversion | 133 | $0.00 | $0.00 | 398 | Direct | โ | View Details | |
EVP and Chief Legal Officer | Restricted Stock Units | Derivative | May 15, 2026 | Exercise/Conversion | 111 | $0.00 | $0.00 | 779 | Direct | โ | View Details |